BSE filing, BSE: 543902. Summary written from the filing by ALFA Finder's alert engine.
Retina Paints Ltd: key numbers
- Share price
- ₹32.84
- Market cap
- ₹50.38 Cr
- Revenue (annual)
- ₹23.74 Cr
- Net profit (annual)
- ₹0.64 Cr
- P/E (TTM)
- 78.8×Sector 41.7×
- Promoter holding
- 53.87%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Retina Paints Ltd
All →Retina Paints Management Change
Retina Paints' Company Secretary and Compliance Officer, Ms. Madhu Solanki, resigned effective 28 October 2026. Her departure as Key Managerial Personnel is disclosed under Regulation 30.
Retina Paints Annual General Meeting
Retina Paints Ltd held its 16th Annual General Meeting on September 30, 2026, transacting business related to financial statements and director re-appointment.
Retina Paints Annual Report
Retina Paints Ltd filed its 16th Annual Report for FY 2025-26 under SEBI Regulation 34(1). No fresh transaction or monetary value is disclosed in this filing.
Retina Paints Annual General Meeting
Retina Paints Ltd will hold its 16th AGM on September 30, 2026. The board approved the annual report and appointed a scrutinizer.
Retina Paints Management Change
Retina Paints re-appointed MVK & Associates, M M R S & Co, and KP Associates as auditors for FY2026-27. The move ensures continued compliance and internal control oversight.
- Execution
- FY 2026-27
Retina Paints H2 FY26 Results: Net Profit ₹0.4 Cr, Down 60.0% YoY
Retina Paints Ltd reported revenue from operations of ₹15.7 Cr (+6.1% YoY) and net profit of ₹0.4 Cr (-60.0% YoY) for H2 FY26.
- Key figure
- Net profit ₹0.4 Cr · -60.0% YoY
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.